BNP Paribas Financial Markets’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$193K Buy
148,815
+140,520
+1,694% +$204K ﹤0.01% 4252
2026
Q1
$12K Sell
8,295
-303
-4% -$480 ﹤0.01% 5184
2025
Q4
$11.9K Buy
8,598
+1,315
+18% +$2.75K ﹤0.01% 5127
2025
Q3
$19.9K Buy
7,283
+4,195
+136% +$14.9K ﹤0.01% 4905
2025
Q2
$10.8K Buy
+3,088
New +$12.2K ﹤0.01% 4824
2024
Q4
Sell
-271
Closed -$206 5538
2024
Q3
$206 Buy
+271
New +$356 ﹤0.01% 4040
2023
Q2
Sell
-3,299
Closed -$9.6K 4017
2023
Q1
$9.6K Sell
3,299
-2,946
-47% -$14.9K ﹤0.01% 3556
2022
Q4
$42.9K Buy
6,245
+6,142
+5,963% +$29K ﹤0.01% 3453
2022
Q3
$328 Sell
103
-1,741
-94% -$6.33K ﹤0.01% 4561
2022
Q2
$5.92K Sell
1,844
-6,404
-78% -$18.6K ﹤0.01% 3804
2022
Q1
$25K Sell
8,248
-102
-1% -$345 ﹤0.01% 3695
2021
Q4
$37.2K Buy
8,350
+3,320
+66% +$16.3K ﹤0.01% 3788
2021
Q3
$33K Buy
5,030
+4,146
+469% +$39.8K ﹤0.01% 3598
2021
Q2
$14.2K Buy
+884
New +$12.2K ﹤0.01% 3631
2020
Q3
Sell
-7,553
Closed -$14.6K 4276
2020
Q2
$14.6K Buy
7,553
+3,360
+80% +$6.89K ﹤0.01% 3539
2020
Q1
$7.92K Buy
4,193
+2,221
+113% +$6.94K ﹤0.01% 4042
2019
Q4
$8.85K Sell
1,972
-113
-5% -$702 ﹤0.01% 4142
2019
Q3
$17.3K Buy
2,085
+638
+44% +$6.97K ﹤0.01% 4009
2019
Q2
$18.1K Sell
1,447
-1,231
-46% -$17.4K ﹤0.01% 3932
2019
Q1
$40.8K Buy
+2,678
New +$44.3K ﹤0.01% 3618

Other funds holding STIM

BNP Paribas Financial Markets's STIM Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Neuronetics (STIM) stake by 1,694% in Q2 2026, buying an estimated $204K and bringing the position to 148,815 shares worth $193K. The position accounts for ﹤0.01% of the portfolio, ranked #4252.

BNP Paribas Financial Markets first reported a position in STIM in Q1 2019 and has held it in 20 quarters since. 70 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • BNP Paribas Financial Markets held 148,815 shares of Neuronetics worth $193K as of Q2 2026.
  • BNP Paribas Financial Markets bought 140,520 Neuronetics shares in Q2 2026, an estimated $204K.
  • Neuronetics made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #4252 holding.
  • BNP Paribas Financial Markets first reported a position in Neuronetics in Q1 2019 and has held it in 20 quarters since.
  • 70 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.